MedPath

A Clinical Study to Evaluate the effect of Kunjal Kriya with and without Yogic Diet in Class I Obesity

Not yet recruiting
Conditions
Other obesity,
Registration Number
CTRI/2022/06/043103
Lead Sponsor
NIMMI A N
Brief Summary

it is an open labeled randomised interventional comparative  clinical study to evaluate the effect of Kunjal kriya with and without yogic diet in class I obesity. the primary outcome will be in relieving symptoms of obesity and secondary outcome will be reduction in body weight , BMI, Waist circumference and Lipid profile. in each group 30 subjects will be recruited and study duration will be 30 days. Kunjal kriya involves drinking of 5% saline water in the quantity of 250 ml and inducing vomiting  voluntarily .

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Subjects between the age 20-45 years irrespective of gender and socio-economic status.
  • Subjects with obesity having BMI from 30 Kg/m2 to 34.99 Kg/m2.
Exclusion Criteria
  • Subjects of Class I Obesity with associated co-morbidities which interfere with the course of the treatment will be excluded.
  • Pregnant women and lactating mother will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
reduction of BMI ,1.BMI, Waist circumference, Hip waist ratio, Mid Arm circumference , Skin fold thickness0th day, 30th day
Secondary Outcome Measures
NameTimeMethod
reduction in reduction of BMI ,1.BMI, Waist circumference, Hip waist ratio, Mid Arm circumference , Skin fold thicknessimprovement in quality of life

Trial Locations

Locations (1)

JSS AYURVEDA MEDICAL COLLEGE AND HOSPITAL

🇮🇳

Mysore, KARNATAKA, India

JSS AYURVEDA MEDICAL COLLEGE AND HOSPITAL
🇮🇳Mysore, KARNATAKA, India
Dr P Sudhakar Reddy
Principal investigator
9916483919
drpsreddy05@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.